(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC

NCT00000679 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

600

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine
DRUG: Zalcitabine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]